An in vitro method for determining the bioaccessibility of pharmaceuticals in wildlife
- 19 February 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 35 (9) , 2349-2357
Abstract
Wildlife can be exposed to human pharmaceuticals via prey that have accumulated the compounds from wastewater, surface water, sediment, and soil. One factor affecting internal absorption of pharmaceuticals is bioaccessibility, the proportion of the compound that enters solution in the gastrointestinal tract. Currently, the bioaccessibility of most pharmaceuticals in prey remains unknown for most wildlife species. The authors evaluated the potential of a 2-compartment in vitro gastrointestinal tract model to compare the bioaccessibility of the antidepressant fluoxetine from invertebrate prey for birds and mammals. Samples of gizzard (or stomach) and intestinal-phase digestive juices were obtained from the in vitro models along with the residual solid material. High-performance liquid chromatographic analysis revealed that the bioaccessibility of fluoxetine in the avian in vitro models was statistically significantly lower than that in the mammalian models as a percentage of what was recovered; however, there were no statistically or biologically significant interspecies difference in terms of the amount recovered per gram of “food” inserted at the start of the simulation. This in vitro model provides a useful method of comparing the bioaccessibility of pharmaceuticals in different prey for species with different gastrointestinal conditions. There is merit for ecological risk assessments in further developing this in vitro approach to improve estimates of internal exposure for organics. Environ Toxicol Chem 2016;35:2349–2357. © 2016 SETACKeywords
Funding Information
- Natural Environment Research Council
- Natural Environment Research Council
This publication has 41 references indexed in Scilit:
- Assessing the exposure risk and impacts of pharmaceuticals in the environment on individuals and ecosystemsBiology Letters, 2013
- Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?Environmental Health Perspectives, 2012
- Colon Extended Physiologically Based Extraction Test (CE-PBET) Increases Bioaccessibility of Soil-Bound PAHEnvironmental Science & Technology, 2011
- Bioaccessibility of mercury from traditional northern country foods measured using an in vitro gastrointestinal model is independent of mercury concentrationScience of The Total Environment, 2009
- Earthworms and in vitro physiologically-based extraction tests: complementary tools for a holistic approach towards understanding risk at arsenic-contaminated sitesEnvironmental Geochemistry and Health, 2008
- Comparative physiology, pharmacology and toxicology of β-blockers: Mammals versus fishAquatic Toxicology, 2007
- Advances in Evaluating the Oral Bioavailability of Inorganics in Soil for Use in Human Health Risk AssessmentEnvironmental Science & Technology, 1999
- Estimation of Lead and Arsenic Bioavailability Using a Physiologically Based Extraction TestEnvironmental Science & Technology, 1996
- Development of an in vitro screening test to evaluate the in vivo bioaccessibility of ingested mine-waste leadEnvironmental Science & Technology, 1993
- The Effect of Temperature and pH on the Stability of Human Pepsin in Stored Gastric Juice: A Method to Prevent Activity LossScandinavian Journal of Gastroenterology, 1986